CLINICAL TRIAL SUMMARY

MDACC Study No:2007-0822 (clinicaltrials.gov NCT No: NCT00633633)
Title:Take Heart: Exercise Intervention for Heart Failure in Cancer Survivors
Principal Investigator:Karen Basen-Engquist
Treatment Agent:None
Study Status:Closed
Study Description:The goal of this behavioral research study is to learn if education and
training about exercise can help to change the lifestyle of cancer survivors
with symptoms of heart failure.

Hide details for General InformationGeneral Information

Disease Group:Cancer Prevention
Phase of Study:N/A
Treatment Agents:None
Treatment Location:Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions
Estimated Length of Stay in Houston:N/A
Supported By:N/A
Return Visit: Participants in the intervention group will come to M.D. Anderson Cancer
Center three times a week for sixteen weeks. Participants will also be seen
every 4 weeks. Participants will come to the BRTC for their follow-up 17-18
weeks after baseline.
Home Care:Participants will be given an accelerometer to wear for one week.
Participants in the intervention group may be asked to exercise at home.


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Karen Basen-Engquist
Dept:Behavioral Science
For Clinical Trial Enrollment:713-792-0919
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults